BioCentury | May 20, 2002
Finance

Ebb & Flow

...was off 9p (21%) to 34.5p on news it had terminated talks to float its Cobra Therapeutics...
BioCentury | Mar 26, 2001
Company News

Profile Therapeutics plc board of directors update

...Therapeutics plc (LSE:PTP), Bognor Regis, U.K. Business: Drug delivery Appointed: Davis Bloxham, acting CEO of Cobra Therapeutics Ltd....
BioCentury | Dec 4, 2000
Clinical News

ML Lab preclinical data

...Researchers at MLB's Cobra Therapeutics Ltd. subsidiary (Keele, U.K.) and colleagues published in Nature Biotechnology that dendritic cells...
BioCentury | Oct 9, 2000
Strategy

Coulter looks to pipeline deals

...while simultaneously providing faster recombinant protein production for research. CLTR (South San Francisco, Calif.) and Cobra Therapeutics Ltd....
BioCentury | Oct 9, 2000
Company News

Coulter Pharma, ML Lab deal

...CLTR and Cobra Therapeutics Ltd. , an MLB subsidiary, will develop and commercialize Cobra’s gene expression technology based...
BioCentury | Oct 3, 2000
Company News

Coulter and Cobra to develop gene expression technology

...CLTR and Cobra Therapeutics, a subsidiary of ML Laboratories (LSE:MLB), will collaborate to develop and commercialize Cobra's...
BioCentury | Jul 24, 2000
Clinical News

Operator repressor titration regulatory update

...MLB's Cobra Therapeutics Ltd. subsidiary (Keele, U.K.) received U.K. approval to manufacture DNA for clinical trials of the...
BioCentury | Jul 3, 2000
Clinical News

CTL102/CB1954 gene therapy: Began Phase I/II testing

...directs conversion of prodrug to cytotoxic compound within tumors Indication: Treat liver cancer Status: MLB's Cobra Therapeutics Ltd....
BioCentury | Mar 27, 2000
Finance

'No dessert, thank you'

...finished the week up 3p at 221.5p after completing its acquisition of gene therapy company Cobra Therapeutics...
BioCentury | Mar 27, 2000
Company News

Cobra, ML Lab deal

...its previously announced acquisition of gene delivery and expression company Cobra (see BioCentury, Feb. 14). Cobra Therapeutics Ltd....
Items per page:
1 - 10 of 33
BioCentury | May 20, 2002
Finance

Ebb & Flow

...was off 9p (21%) to 34.5p on news it had terminated talks to float its Cobra Therapeutics...
BioCentury | Mar 26, 2001
Company News

Profile Therapeutics plc board of directors update

...Therapeutics plc (LSE:PTP), Bognor Regis, U.K. Business: Drug delivery Appointed: Davis Bloxham, acting CEO of Cobra Therapeutics Ltd....
BioCentury | Dec 4, 2000
Clinical News

ML Lab preclinical data

...Researchers at MLB's Cobra Therapeutics Ltd. subsidiary (Keele, U.K.) and colleagues published in Nature Biotechnology that dendritic cells...
BioCentury | Oct 9, 2000
Strategy

Coulter looks to pipeline deals

...while simultaneously providing faster recombinant protein production for research. CLTR (South San Francisco, Calif.) and Cobra Therapeutics Ltd....
BioCentury | Oct 9, 2000
Company News

Coulter Pharma, ML Lab deal

...CLTR and Cobra Therapeutics Ltd. , an MLB subsidiary, will develop and commercialize Cobra’s gene expression technology based...
BioCentury | Oct 3, 2000
Company News

Coulter and Cobra to develop gene expression technology

...CLTR and Cobra Therapeutics, a subsidiary of ML Laboratories (LSE:MLB), will collaborate to develop and commercialize Cobra's...
BioCentury | Jul 24, 2000
Clinical News

Operator repressor titration regulatory update

...MLB's Cobra Therapeutics Ltd. subsidiary (Keele, U.K.) received U.K. approval to manufacture DNA for clinical trials of the...
BioCentury | Jul 3, 2000
Clinical News

CTL102/CB1954 gene therapy: Began Phase I/II testing

...directs conversion of prodrug to cytotoxic compound within tumors Indication: Treat liver cancer Status: MLB's Cobra Therapeutics Ltd....
BioCentury | Mar 27, 2000
Finance

'No dessert, thank you'

...finished the week up 3p at 221.5p after completing its acquisition of gene therapy company Cobra Therapeutics...
BioCentury | Mar 27, 2000
Company News

Cobra, ML Lab deal

...its previously announced acquisition of gene delivery and expression company Cobra (see BioCentury, Feb. 14). Cobra Therapeutics Ltd....
Items per page:
1 - 10 of 33